Drug Profile
Research programme: serotonin 2C receptor agonists - Pfizer
Alternative Names: CP-809101; PF-3246799Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class Small molecules
- Mechanism of Action Serotonin 2C receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity; Schizophrenia; Sexual function disorders; Urinary incontinence
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Obesity in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sexual-function-disorders in United Kingdom